Medications for opioid use disorder for healthcare and addiction professionals, policymakers, patients, and families
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment--methadone, naltrexone, and buprenorphine--and the other strategies and services needed to support people in recovery
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Rockville, Md.]
U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment
2021, 2021
|
| Edition: | Updated 2021 |
| Series: | TIP
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment--methadone, naltrexone, and buprenorphine--and the other strategies and services needed to support people in recovery |
|---|---|
| Item Description: | "PEP21-02-01-002" |
| Physical Description: | 1 PDF file (various pagings) illustrations |